(NTLA) Intellia Therapeutics Renko charts technical analysis
(NTLA) Intellia Therapeutics Renko charts technical analysis Renko analysis of Intellia Therapeutics | Buy/Sell Intellia Therapeutics
Intellia Therapeutics trades in USA in Health Care sector.
10 day averaged volume of Intellia Therapeutics is 3581084
| Date | Closing Price | Open | High | Low | Volume |
| 17 Wed Dec 2025 | 8.79 | 9.13 | 9.55 | 8.78 | 3.282 Mn |
| 16 Tue Dec 2025 | 9.12 | 9.00 | 9.26 | 8.91 | 2.5 Mn |
| 15 Mon Dec 2025 | 9.14 | 9.08 | 9.23 | 8.90 | 3.952 Mn |
| 12 Fri Dec 2025 | 9.02 | 9.61 | 9.68 | 9.02 | 3.406 Mn |
| 11 Thu Dec 2025 | 9.55 | 9.33 | 9.67 | 9.25 | 3.068 Mn |
| 10 Wed Dec 2025 | 9.37 | 9.27 | 9.70 | 9.15 | 2.754 Mn |
| 09 Tue Dec 2025 | 9.30 | 9.36 | 9.60 | 9.22 | 3.138 Mn |
| 08 Mon Dec 2025 | 9.44 | 9.89 | 9.95 | 9.35 | 3.459 Mn |
| 05 Fri Dec 2025 | 9.61 | 9.59 | 9.66 | 9.36 | 4.03 Mn |
| 04 Thu Dec 2025 | 9.75 | 8.98 | 9.92 | 8.85 | 4.758 Mn |
Indicators analysis of Intellia Therapeutics (NTLA)
Price action analysis of Intellia Therapeutics ( (NTLA) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Intellia Therapeutics ( (NTLA) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Intellia Therapeutics ( (NTLA) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Intellia Therapeutics ( (NTLA) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Intellia Therapeutics stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Intellia Therapeutics in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Intellia Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Intellia Therapeutics in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Intellia Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 9.33 and Intellia Therapeutics (NTLA) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Intellia Therapeutics (NTLA) stock. Volume based technical analysis of Intellia Therapeutics (NTLA) stock is negative.
Intellia Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Renko charts
Price action analysis of Intellia Therapeutics ( (NTLA) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Intellia Therapeutics ( (NTLA) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Intellia Therapeutics ( (NTLA) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Intellia Therapeutics ( (NTLA) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Intellia Therapeutics stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Intellia Therapeutics in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Intellia Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Intellia Therapeutics in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Intellia Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 9.33 and Intellia Therapeutics (NTLA) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Intellia Therapeutics (NTLA) stock. Volume based technical analysis of Intellia Therapeutics (NTLA) stock is negative.
Intellia Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

